186 related articles for article (PubMed ID: 37998507)
21. Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.
Alexopoulos E; Spargias K; Kyrzopoulos S; Manginas A; Pavlides G; Voudris V; Lerakis S; McLean DS; Cokkinos DV
Am J Med Sci; 2010 Jan; 339(1):25-30. PubMed ID: 19996728
[TBL] [Abstract][Full Text] [Related]
22. Optimal contrast agents for vascular imaging on computed tomography: iodixanol versus iohexol.
Pannu HK; Thompson RE; Phelps J; Magee CA; Fishman EK
Acad Radiol; 2005 May; 12(5):576-84. PubMed ID: 15866130
[TBL] [Abstract][Full Text] [Related]
23. Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.
Zhang J; Jiang Y; Rui Q; Chen M; Zhang N; Yang H; Zhou Y
Medicine (Baltimore); 2018 May; 97(18):e0617. PubMed ID: 29718868
[TBL] [Abstract][Full Text] [Related]
24. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
[TBL] [Abstract][Full Text] [Related]
25. Nephrotoxic effects in high-risk patients undergoing angiography.
Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Berg KJ;
N Engl J Med; 2003 Feb; 348(6):491-9. PubMed ID: 12571256
[TBL] [Abstract][Full Text] [Related]
26. CT of deep venous thrombosis and pulmonary embolus: does iso-osmolar contrast agent improve vascular opacification?
Goodman LR; Gulsun M; Nagy P; Washington L
Radiology; 2005 Mar; 234(3):923-8. PubMed ID: 15665223
[TBL] [Abstract][Full Text] [Related]
27. [Selection of contrast media: current status of understanding].
Briguori C
G Ital Cardiol (Rome); 2009 Feb; 10(2):79-87. PubMed ID: 19348144
[TBL] [Abstract][Full Text] [Related]
28. Image quality and diagnostic accuracy of different dosages of iodixanol in computed tomography angiography and perfusion of overweight patients with coronary artery stenosis: A feasibility study.
Tang X; Zhang Y; Wang T; Ma Y; Shi H; Yin R; Zou P; Cao J; Pan C
Med Eng Phys; 2022 Dec; 110():103818. PubMed ID: 35618562
[TBL] [Abstract][Full Text] [Related]
29. The effect of scan and patient parameters on the diagnostic performance of AI for detecting coronary stenosis on coronary CT angiography.
Jonas RA; Barkovich E; Choi AD; Griffin WF; Riess J; Marques H; Chang HJ; Choi JH; Doh JH; Her AY; Koo BK; Nam CW; Park HB; Shin SH; Cole J; Gimelli A; Khan MA; Lu B; Gao Y; Nabi F; Nakazato R; Schoepf UJ; Driessen RS; Bom MJ; Thompson RC; Jang JJ; Ridner M; Rowan C; Avelar E; Généreux P; Knaapen P; de Waard GA; Pontone G; Andreini D; Guglielmo M; Al-Mallah MH; Jennings RS; Crabtree TR; Earls JP
Clin Imaging; 2022 Apr; 84():149-158. PubMed ID: 35217284
[TBL] [Abstract][Full Text] [Related]
30. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
Bertrand ME; Esplugas E; Piessens J; Rasch W
Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Accuracy of Noninvasive 64-row Computed Tomographic Coronary Angiography (CCTA) Compared with Myocardial Perfusion Imaging (MPI): The PICTURE Study, A Prospective Multicenter Trial.
Budoff MJ; Li D; Kazerooni EA; Thomas GS; Mieres JH; Shaw LJ
Acad Radiol; 2017 Jan; 24(1):22-29. PubMed ID: 27771227
[TBL] [Abstract][Full Text] [Related]
32. Up to 50-fold increase in urine viscosity with iso-osmolar contrast media in the rat.
Seeliger E; Becker K; Ladwig M; Wronski T; Persson PB; Flemming B
Radiology; 2010 Aug; 256(2):406-14. PubMed ID: 20529990
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
[TBL] [Abstract][Full Text] [Related]
34. Intra-arterial and intravenous applications of Iosimenol 340 injection, a new non-ionic, dimeric, iso-osmolar radiographic contrast medium: phase 2 experience.
Meurer K; Laniado M; Hosten N; Kelsch B; Hogstrom B
Acta Radiol; 2015 Jun; 56(6):702-8. PubMed ID: 24938661
[TBL] [Abstract][Full Text] [Related]
35. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary embolism: prospective comparison of iso-osmolar and low-osmolarity nonionic contrast agents for contrast enhancement at CT angiography.
Bédard JP; Blais C; Patenaude YG; Monga E
Radiology; 2005 Mar; 234(3):929-33. PubMed ID: 15681688
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis of coronary artery disease in patients with atrial fibrillation using low tube voltage coronary CT angiography with isotonic low-concentration contrast agent.
Pan Y; Huang Q; Zhu Y; Zou X; Chu H; Du X; Li A; Bu S
Int J Cardiovasc Imaging; 2019 Dec; 35(12):2239-2248. PubMed ID: 31363878
[TBL] [Abstract][Full Text] [Related]
38. Low-osmolar monomeric versus iso-osmolar dimeric contrast media: an intra-individual comparison in CT angiography using an animal model.
Behrendt FF; Pietsch H; Jost G; Keil S; Mottaghy FM; Günther RW; Mahnken AH
J Med Imaging Radiat Oncol; 2011 Apr; 55(2):170-5. PubMed ID: 21501406
[TBL] [Abstract][Full Text] [Related]
39. Recent clinical trials of iodixanol.
Erdogan A; Davidson CJ
Rev Cardiovasc Med; 2003; 4 Suppl 5():S43-50. PubMed ID: 14668709
[TBL] [Abstract][Full Text] [Related]
40. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
